Skip to content
10-Q

Quarterly Report

BioTelemetry, Inc.

0001574774-19-000060

← back to feed
Filed
Nov 5, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 28, 2019 33.99M sh
Long Term Debt Q3 2019 · Sep 30, 2019 $182.83M
Long Term Debt Q3 2019 · Dec 31, 2018 $193.42M
Short Term Debt Q3 2019 · Sep 30, 2019 $12.81M
Short Term Debt Q3 2019 · Dec 31, 2018 $5.13M
Stockholders Equity Q3 2019 · Sep 30, 2019 $360.91M
Stockholders Equity Q3 2019 · Dec 31, 2018 $310.49M
Current Liabilities Q3 2019 · Sep 30, 2019 $61.08M
Current Liabilities Q3 2019 · Dec 31, 2018 $49.62M
Total Liabilities Q3 2019 · Sep 30, 2019 $315.26M
Total Liabilities Q3 2019 · Dec 31, 2018 $276.32M
Current Assets Q3 2019 · Sep 30, 2019 $150.14M
Current Assets Q3 2019 · Dec 31, 2018 $146.66M
Total Assets Q3 2019 · Sep 30, 2019 $676.16M
Total Assets Q3 2019 · Dec 31, 2018 $586.8M
Shares Diluted Q3 2019 · Sep 30, 2018 35.92M sh
Shares Diluted Q3 2019 · Sep 30, 2018 35.57M sh
Capex Q3 2019 · Sep 30, 2018 $17.5M
Operating Cash Flow Q3 2019 · Sep 30, 2018 $44.29M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $63.12M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $36.02M
Eps Diluted Q3 2019 · Sep 30, 2018 $0.45
Eps Diluted Q3 2019 · Sep 30, 2018 $0.91
Eps Basic Q3 2019 · Sep 30, 2018 $0.48
Eps Basic Q3 2019 · Sep 30, 2018 $1.00
Sga Expense Q3 2019 · Sep 30, 2018 $26.33M
Sga Expense Q3 2019 · Sep 30, 2018 $81.79M
Rd Expense Q3 2019 · Sep 30, 2018 $2.43M
Rd Expense Q3 2019 · Sep 30, 2018 $8.45M
Operating Income Q3 2019 · Sep 30, 2018 $17.38M
Operating Income Q3 2019 · Sep 30, 2018 $35.24M
Gross Profit Q3 2019 · Sep 30, 2018 $62.74M
Gross Profit Q3 2019 · Sep 30, 2018 $186.54M
Cost Of Revenue Q3 2019 · Sep 30, 2018 $37.28M
Cost Of Revenue Q3 2019 · Sep 30, 2018 $109.33M